List of Excipients in API benzonatate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing benzonatate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | TESSALON | benzonatate | 0069-0122 | D&C YELLOW NO. 10 | |
| Pfizer Laboratories Div Pfizer Inc | TESSALON | benzonatate | 0069-0122 | GELATIN | |
| Pfizer Laboratories Div Pfizer Inc | TESSALON | benzonatate | 0069-0122 | GLYCERIN | |
| Pfizer Laboratories Div Pfizer Inc | TESSALON | benzonatate | 0069-0122 | METHYLPARABEN | |
| Pfizer Laboratories Div Pfizer Inc | TESSALON | benzonatate | 0069-0122 | PROPYLPARABEN | |
| Greenstone LLC | BENZONATATE | benzonatate | 59762-1122 | D&C YELLOW NO. 10 | |
| Greenstone LLC | BENZONATATE | benzonatate | 59762-1122 | GELATIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing benzonatate
Detailed excipient profiles for benzonatate
Excipient focus: ALCOHOL
benzonatate drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Life Line Home Care Services Inc | benzonatate | 75921-133 |
| >Company | >Ingredient | >NDC |
benzonatate drug variants not containing ALCOHOL
Excipient focus: AMMONIA
benzonatate drug variants containing AMMONIA
benzonatate drug variants not containing AMMONIA
Excipient focus: BUTYL ALCOHOL
benzonatate drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | benzonatate | 23155-898 |
| Acella Pharmaceuticals LLC | benzonatate | 42192-617 |
| Proficient Rx LP | benzonatate | 71205-659 |
| Proficient Rx LP | benzonatate | 71205-662 |
| Proficient Rx LP | benzonatate | 71205-885 |
| >Company | >Ingredient | >NDC |
benzonatate drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
benzonatate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mikart LLC | benzonatate | 46672-280 |
| >Company | >Ingredient | >NDC |
benzonatate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
benzonatate drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mikart LLC | benzonatate | 46672-280 |
| >Company | >Ingredient | >NDC |
benzonatate drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C YELLOW NO. 10
benzonatate drug variants containing D&C YELLOW NO. 10
benzonatate drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
benzonatate drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | benzonatate | 23155-898 |
| >Company | >Ingredient | >NDC |
benzonatate drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: DIMETHICONE
benzonatate drug variants containing DIMETHICONE
benzonatate drug variants not containing DIMETHICONE
Excipient focus: FD&C BLUE NO. 1
benzonatate drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mikart LLC | benzonatate | 46672-280 |
| >Company | >Ingredient | >NDC |
benzonatate drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C RED NO. 40
benzonatate drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Mikart LLC | benzonatate | 46672-280 |
| >Company | >Ingredient | >NDC |
benzonatate drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
benzonatate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Mikart LLC | benzonatate | 46672-280 |
| >Company | >Ingredient | >NDC |
benzonatate drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERROSOFERRIC OXIDE
benzonatate drug variants containing FERROSOFERRIC OXIDE
benzonatate drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
benzonatate drug variants containing GELATIN
benzonatate drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
benzonatate drug variants containing GLYCERIN
benzonatate drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Mikart LLC | benzonatate | 46672-280 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
benzonatate drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mikart LLC | benzonatate | 46672-280 |
| >Company | >Ingredient | >NDC |
benzonatate drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
benzonatate drug variants containing HYPROMELLOSE
benzonatate drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
benzonatate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | benzonatate | 31722-956 |
| Redpharm drug inc | benzonatate | 67296-1833 |
| NuCare PharmaceuticalsInc | benzonatate | 68071-2562 |
| XLCare Pharmaceuticals Inc | benzonatate | 72865-117 |
| >Company | >Ingredient | >NDC |
benzonatate drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
benzonatate drug variants containing ISOPROPYL ALCOHOL
benzonatate drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LECITHIN, SOYBEAN
benzonatate drug variants containing LECITHIN, SOYBEAN
benzonatate drug variants not containing LECITHIN, SOYBEAN
Excipient focus: LIGHT MINERAL OIL
benzonatate drug variants containing LIGHT MINERAL OIL
benzonatate drug variants not containing LIGHT MINERAL OIL
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
benzonatate drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
benzonatate drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: METHYLPARABEN
benzonatate drug variants containing METHYLPARABEN
benzonatate drug variants not containing METHYLPARABEN
Excipient focus: METHYLPARABEN SODIUM
benzonatate drug variants containing METHYLPARABEN SODIUM
benzonatate drug variants not containing METHYLPARABEN SODIUM
Excipient focus: NITROGEN
benzonatate drug variants containing NITROGEN
benzonatate drug variants not containing NITROGEN
Excipient focus: PROPYLENE GLYCOL
benzonatate drug variants containing PROPYLENE GLYCOL
benzonatate drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
benzonatate drug variants containing PROPYLPARABEN
benzonatate drug variants not containing PROPYLPARABEN
Excipient focus: PROPYLPARABEN SODIUM
benzonatate drug variants containing PROPYLPARABEN SODIUM
benzonatate drug variants not containing PROPYLPARABEN SODIUM
Excipient focus: SHELLAC
benzonatate drug variants containing SHELLAC
benzonatate drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
benzonatate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Acella Pharmaceuticals LLC | benzonatate | 42192-617 |
| Mikart LLC | benzonatate | 46672-280 |
| Proficient Rx LP | benzonatate | 71205-659 |
| Proficient Rx LP | benzonatate | 71205-662 |
| Proficient Rx LP | benzonatate | 71205-885 |
| >Company | >Ingredient | >NDC |
benzonatate drug variants not containing SILICON DIOXIDE
Excipient focus: SORBITOL
benzonatate drug variants containing SORBITOL
benzonatate drug variants not containing SORBITOL
Excipient focus: TITANIUM DIOXIDE
benzonatate drug variants containing TITANIUM DIOXIDE
benzonatate drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
benzonatate drug variants containing WATER
benzonatate drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
